151 related articles for article (PubMed ID: 37904707)
1. The CD2-CD58 axis: A novel marker predicting poor prognosis in patients with low-grade gliomas and potential therapeutic approaches.
Wu M; Chen Y; Hua G; Chunhui L
Immun Inflamm Dis; 2023 Oct; 11(10):e1022. PubMed ID: 37904707
[TBL] [Abstract][Full Text] [Related]
2. Costimulatory Function of Cd58/Cd2 Interaction in Adaptive Humoral Immunity in a Zebrafish Model.
Shao T; Shi W; Zheng JY; Xu XX; Lin AF; Xiang LX; Shao JZ
Front Immunol; 2018; 9():1204. PubMed ID: 29904386
[TBL] [Abstract][Full Text] [Related]
3. CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation.
Crawford K; Stark A; Kitchens B; Sternheim K; Pantazopoulos V; Triantafellow E; Wang Z; Vasir B; Larsen CE; Gabuzda D; Reinherz E; Alper CA
Blood; 2003 Sep; 102(5):1745-52. PubMed ID: 12714509
[TBL] [Abstract][Full Text] [Related]
4. CD58 Immunobiology at a Glance.
Zhang Y; Liu Q; Yang S; Liao Q
Front Immunol; 2021; 12():705260. PubMed ID: 34168659
[TBL] [Abstract][Full Text] [Related]
5. CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma.
Ghosh A; Marques-Piubelli ML; Wang X; Sheu TG; Cheng J; Khan K; Lu W; Manning J; Tang G; Solis LM; Vega F
Virchows Arch; 2022 Oct; 481(4):659-663. PubMed ID: 35622145
[TBL] [Abstract][Full Text] [Related]
6. A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals.
Demetriou P; Abu-Shah E; Valvo S; McCuaig S; Mayya V; Kvalvaag A; Starkey T; Korobchevskaya K; Lee LYW; Friedrich M; Mann E; Kutuzov MA; Morotti M; Wietek N; Rada H; Yusuf S; Afrose J; Siokis A; ; Meyer-Hermann M; Ahmed AA; Depoil D; Dustin ML
Nat Immunol; 2020 Oct; 21(10):1232-1243. PubMed ID: 32929275
[TBL] [Abstract][Full Text] [Related]
7. The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation.
Chaudhuri S; Singh MK; Bhattacharya D; Acharya S; Chatterjee S; Kumar P; Bhattacharjee P; Basu AK; Sa G; Das T; Ghosh TK; Chaudhuri S
J Neurooncol; 2014 Oct; 120(1):19-31. PubMed ID: 25026997
[TBL] [Abstract][Full Text] [Related]
8. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
9. The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity.
Ho P; Melms JC; Rogava M; Frangieh CJ; Poźniak J; Shah SB; Walsh Z; Kyrysyuk O; Amin AD; Caprio L; Fullerton BT; Soni RK; Ager CR; Biermann J; Wang Y; Khosravi-Maharlooei M; Zanetti G; Mu M; Fatima H; Moore EK; Vasan N; Bakhoum SF; Reiner SL; Bernatchez C; Sykes M; Mace EM; Wucherpfennig KW; Schadendorf D; Bechter O; Shah P; Schwartz GK; Marine JC; Izar B
Cancer Cell; 2023 Jul; 41(7):1207-1221.e12. PubMed ID: 37327789
[TBL] [Abstract][Full Text] [Related]
10. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection.
Rölle A; Halenius A; Ewen EM; Cerwenka A; Hengel H; Momburg F
Eur J Immunol; 2016 Oct; 46(10):2420-2425. PubMed ID: 27469079
[TBL] [Abstract][Full Text] [Related]
11. CD2-SLFA3/T11TS interaction facilitates immune activation and glioma regression by apoptosis.
Sarkar S; Ghosh A; Mukherjee J; Chaudhuri S; Chaudhuri S
Cancer Biol Ther; 2004 Nov; 3(11):1121-8. PubMed ID: 15467439
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in mice.
Gokhale A; Kanthala S; Latendresse J; Taneja V; Satyanarayanajois S
Chem Biol Drug Des; 2013 Jul; 82(1):106-18. PubMed ID: 23530775
[TBL] [Abstract][Full Text] [Related]
13. Leishmania donovani resistant to Ambisome or Miltefosine exacerbates CD58 expression on NK cells and promotes trans-membrane migration in association with CD2.
Shivam P; Kumari S; Jamal F; Kumar V; Kumar M; Bimal S; Narayan S; Das VNR; Pandey K; Gupta AK; Das P; Singh SK
Cytokine; 2017 Aug; 96():54-58. PubMed ID: 28324803
[TBL] [Abstract][Full Text] [Related]
14. Adhesive bond dynamics in contacts between T lymphocytes and glass-supported planar bilayers reconstituted with the immunoglobulin-related adhesion molecule CD58.
Dustin ML
J Biol Chem; 1997 Jun; 272(25):15782-8. PubMed ID: 9188475
[TBL] [Abstract][Full Text] [Related]
15. A model for CD2/CD58-mediated adhesion strengthening.
Shao JY; Yu Y; Dustin ML
Ann Biomed Eng; 2005 Apr; 33(4):483-93. PubMed ID: 15909654
[TBL] [Abstract][Full Text] [Related]
16. Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58.
Veldman J; Visser L; Huberts-Kregel M; Muller N; Hepkema B; van den Berg A; Diepstra A
Blood; 2020 Nov; 136(21):2437-2441. PubMed ID: 32589698
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognosis-related gene features in low-grade glioma based on ssGSEA.
He Y; Lin Z; Tan S
Front Oncol; 2022; 12():1056623. PubMed ID: 36591509
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration.
Wu S; Miao K; Wang L; Ma Y; Wu X
Med Oncol; 2022 Jan; 39(2):27. PubMed ID: 35018510
[TBL] [Abstract][Full Text] [Related]
19. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59.
Hahn WC; Menu E; Bothwell AL; Sims PJ; Bierer BE
Science; 1992 Jun; 256(5065):1805-7. PubMed ID: 1377404
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-A resolution.
Ikemizu S; Sparks LM; van der Merwe PA; Harlos K; Stuart DI; Jones EY; Davis SJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4289-94. PubMed ID: 10200255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
